The pharmaceutical industry, with its wealth of sensitive data and critical research, must remain at the forefront of cybersecurity efforts. By integrating cybersecurity considerations into every ...

By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

WHO has released a new landscape analysis that exposes critical gaps in global research and development (R&D) efforts related to cancer. The report reveals that despite rapid advancements in clinical ...

Investigator-initiated clinical trials (IITs) are at the core of innovative thinking in health research generating data in real-world settings that influence global policy. Although diminished funding ...

Recent advances in understanding venous malformation disease pathogenesis highlight the PI3K/AKT/mTOR pathway as a key driver of disease ...

Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH. Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for m ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective treatments for decades. The brains of people who die with Alzheimer’s show a ...

India has the opportunity and the responsibility to reimagine primary care as its most vital investment and this must start with those who deliver it ...

President Donald Trump and U.S. Health and Human Services Secretary Robert F. Kennedy Jr. have officially found scapegoats to blame for rising rates of reported autism cases. In a report published ...